SG/PUT/SARTORIUS STEDIM BIO/170/0.025/21.06.24 Share Price

Warrant

771SS

DE000SW30GR9

Market Closed - Euronext Paris 17:30:00 31/05/2024 BST
0.105 EUR -.--% Intraday chart for SG/PUT/SARTORIUS STEDIM BIO/170/0.025/21.06.24
6 months-72.73%
Current year-53.33%
Date Price Change
31/05/24 0.105 -.--%
30/05/24 0.105 -.--%
29/05/24 0.105 -.--%
28/05/24 0.105 -.--%
27/05/24 0.105 -.--%

Real-time Euronext Paris

Last update May 31, 2024 at 05:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer Société Générale Société Générale
771SS
ISINDE000SW30GR9
Date issued 26/09/2023
Strike 170
Maturity 21/06/2024 (20 Days)
Parity 40 : 1
Emission price 0.35
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.765
Lowest since issue 0.04
Delta-0.27x
Omega 11.57
Premium9.23x
Gearing43.49x
Moneyness 0.9307
Difference Strike -12.65
Difference Strike %-7.44%
Spread 0.01
Spread %9.09%
Theoretical value 0.1050
Implied Volatility 55.22 %
Total Loss Probability 68.87 %
Intrinsic value 0.000000
Present value 0.1050
Break even 165.80 €
Theta-0.03x
Vega0x
Rho-0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
182.6 EUR
Average target price
248.8 EUR
Spread / Average Target
+36.24%
Consensus
  1. Stock Market
  2. Warrants
  3. 771SS Warrant